Have we finally found an effective vaccine against malaria?
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
Joshua Mitchell reviews the debate over the role of serotonin in depression, and the evidence on whether antidepressants do actually work.
Rakhshan Kamran discusses how patient-reported outcome measures should be applied in gender-affirming care and other healthcare settings.
New research shows that more than 2 million people in the UK are now suffering from long COVID. Megan Perry discusses what might be causing the condition and how scientists are trying to cure it.
New research has found a novel population of T-cells that may be more successful than current immunotherapy treatments at targeting cancer cells. James O’Brien discusses.
For years medications have been overprescribed by doctors, costing millions and harming the environment. Amy Booth discusses how green social prescribing may be the answer to reduce these costs and help support people with nature-based interventions.
Max Cowan explores the possibilities created by human genome sequencing and the considerations that need to be put in place for its widespread and commercial use.
Trials of a male contraceptive pill have been successful at preventing pregnancy in mouse models. Isabella Kwiecinski discusses how this form of non-hormonal contraceptive works and the safety concerns that need to be addressed before its clinical use.
Megan Lee explores the approaches being taken to stop aging in its tracks and the ethical issues these studies produce.
By Karen Heathcote We’ve seen and heard plenty about vaccines over the last couple of years, with news outlets all over the world proudly showing images of people receiving their COVID-19 vaccination jabs. However, a new vaccine that is about to enter its next phase of trials in Oxford won’t be administered as an injection…